BCL2A1 and central nervous system cancer: Glioma was classified as grades II-IV according to the degree of malignancy, and public TCGA, CGGA, Rembrandt and Gravdendeel datasets indicated that BCL2A1 expression increased with increasing glioma grade (Figure 2A).